Researchers developed a molecule that targets bacterial cells by two different mechanisms–attacking the cell membrane and disabling folate synthesis. This molecule seems to prevent bacteria from developing antibiotic-resistance. Continue reading Antibiotic uses multiple mechanisms to avoid resistance
Current polio vaccines have been successful in nearly eradicating polio in the world. Unfortunately, there have been emerging cases of polio in recent years. To combat this, scientists have designed a new oral poliovirus vaccine that could result in a new and safer polio vaccine. Continue reading Redesigning the polio vaccine – Lessons from evolution
Scientists use 3D printed brain tissue and cancer to quickly test drug efficacy. Continue reading 3D-Printed Brain Helps Scientists Study Cancer and Test Drugs
New research from Cedars-Sinai suggests that patients with young-onset Parkinson’s may have been born with the beginnings of the disorder. Continue reading People With Young-Onset Parkinson’s May Have Been Born With It
CIFAR Fellows’s paper questions whether diabetes, heart attacks and strokes are actually non-communicable diseases (NCDs). Microbiota (bacteria, viruses, fungi) that spread flu, HIV/AIDS, may also carry NCDs. People with NCDs have damaged microbiota, causing disease when transmitted into healthy animals. Spouses and cohabitants’ shared lifestyles and environments also lead to gut bacteria transfer.
Continue reading Is diabetes communicable?
Scientists have developed a biodegradable ultrasound speaker that can be placed inside the brain. When activated, it makes the blood-brain barrier permeable, potentially allowing certain drugs such as brain cancer chemotherapy and antidepressants to reaching their destination more easily. Continue reading Ultrasound speaker implant that can open a door to your brain
Flu shots have an exciting new role in the world of cancer therapy! A recent study shows that flu vaccines could be used to boost the effects of cancer immunotherapy. Continue reading Take your flu shots! Fighting cancer with flu vaccines.
A new migraine medication called ubrogepant recently passed a large scale phase 3 clinical trial. This medication may be able to help treat patients that cannot tolerate or do not respond to the most common types of migraine medication. Continue reading New migraine medication passes clinical trial
by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and they can take up to a decade to fully complete. Not only can this represent a substantial strain on a pharmaceutical company, it also … Continue reading Virtual Clinical Trials: Testing new drugs from afar
Doctors at Boston Children’s Hospital engineered a unique medicine to treat a young girl’s disease: they reverse engineered a blocker from her DNA to inhibit the gene causing the disease. Continue reading Individual Genetic Medicine Helps Treat Genetic Disease